Fundraising Fox

Lucy O. Day

Chief Financial Officer at AN2 Therapeutics

San Francisco Bay Area

Find your path to Lucy

58 people in our graph share verified history with Lucy — schools, employers, funds. One of them is your warm intro.

Bert RobertsunlockedLucy: together at Ey (1990)
×5Lucy: together at Bank of America
×5Lucy: together at Ey
Lucy: together at AN2 Therapeutics

Chief Financial Officer at AN2 Therapeutics

Intro paths

→

In turn, Lucy can intro founders to AN2 Therapeutics's investors below.

AN2 Therapeutics's investors · 7

Adjuvant CapitalNew York · $10M – $25M checks · since 2026BioRock VenturesSan Francisco · since 2026Biotechnology Value FundSan FranciscoFlucas VenturesJupiter · $100K – $5M checks · since 2026Hatteras Venture PartnersResearch Triangle · $500K – $4M checks · since 2026Mountain Group CapitalNashville · since 2026RA CapitalBoston · since 2026

Co-founders at AN2 Therapeutics

JS
Joseph S. ZakrzewskiCo-Founder & Director
EEEric Easom
Eric EasomCo-Founder, President & CEO
GH
George H. TalbotCo-Founder & Senior Clinical Advisor
MR
Michael R.K. (Dickon) AlleyCo-Founder, SVP Research Fellow, Head of Biology

Experience

  1. AN2 Therapeutics, Inc.Chief Financial Officercurrent2019 — present
  2. Anacor PharmaceuticalsChief Financial Officer/Vice President2002 — 2016
  3. Centaur pharmaChief Financial Officer1994 — 2002
  4. Bank of AmericaVice President Financial Reporting & Consolidation1990 — 1994
  5. EYAudit Manager1983 — 1990

Skills & more

  • Certified Public Accountant in California (non-active)

From Lucy's professional profile.

Frequently asked questions

Who is Lucy O. Day?
Chief Financial Officer at AN2 Therapeutics
Where does Lucy O. Day work?
Lucy O. Day is Chief Financial Officer at AN2 Therapeutics.
Where did Lucy O. Day go to school?
Lucy O. Day studied at University of California, Berkeley (Bachelor of Arts - BA).

Same school

Also attended University of California, Berkeley2,000

Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport

+ 1,994 more

Shared employers

Also worked at AN2 Therapeutics, Inc.4

Kabeer AzizCo-Founder and Partner at Adjuvant CapitalEric EasomExecutive Officer, Director at AN2 TherapeuticsJosh EizenChief Legal Officer and Chief Operating Officer at AN2 TherapeuticsCameron TrenorChief Medical Officer at AN2 Therapeutics

Also worked at Anacor Pharmaceuticals3

Angie YouSenior Advisor at Frazier Life SciencesAnders HovePartner at ACORN BIOVENTURESEric EasomExecutive Officer, Director at AN2 Therapeutics

Also worked at Bank of America477

Kirsten GreenFounder and Managing Partner at Forerunner VenturesMatt CherianVenture Partner at Monta Vista CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalAndrew WallaceVice President, Revolution Growth at RevolutionWill QuistGP at Slow VenturesChris FeeneySenior Fellow, Bank Policy Institute at MissionOG

+ 471 more

Also worked at EY2,000

Tyler WilsonSenior Accountant at Felicis VenturesSandra SchwarzerInvestor at Index VenturesLinn Hege AuneInvestor at InvestinorTorjusInvestor at InvestinorAngela ToyPartner & COO at Golden Gate VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures

+ 1,994 more